borderline significantp=0.048
There was a borderline significant increase in epilepsy (OR:1.92, 95% CI: 1.01 to 3.29, p=0.048).
There was a borderline significant increase in epilepsy (OR:1.92, 95% CI: 1.01 to 3.29, p=0.048).
We also found trends towards other clinical features of CADASIL being more common with these variants with a marginally significant association with epilepsy, and a non-significant trend towards increased risk of migraine.